Johnson & Johnson to stop selling talc-based baby powder worldwide in 2023

Its talc-based powder, which has not been sold in the US and Canada as of 2020, is at the center of tens of thousands of lawsuits filed by women who developed ovarian cancer after using ordinary talc

Johnson & Johnson says it remains confident in the safety of the product. But in a statement Friday, the company said it would stop selling the talc-based powder worldwide next year as part of a “worldwide portfolio assessment.”

“We are constantly evaluating and optimizing our portfolio to best prepare the business for long-term growth,” the company said in a statement. “This transition will help simplify our product offerings, enable sustainable innovation, and meet the needs of our consumers, customers and changing global trends.”

Several talc companies have placed warning labels on their products, but Johnson and Johnson (JNJ) argued that such a label would be confusing because it matches its product. Some scientific studies have shown that women have an increased risk of developing ovarian cancer when using talcum powder in the genital area, while others do not.
Lawsuits have been filed against the company alleging that the asbestos in its talc causes cancer. In 2018, a St. Louis jury gave the company a $4.7 billion verdict, saying the company was negligent in failing to warn consumers of the potential health risks associated with its baby powder.

“Our position regarding the safety of our cosmetic talc remains unchanged. We strongly support decades of independent scientific analysis by medical experts around the world, which confirms that Johnson’s talc-based baby powder is safe, free of asbestos, and does not cause cancer. “, the post said on Friday.

Leave a Reply

Your email address will not be published. Required fields are marked *